From October 1, 2023 to December 19, 2023, the company has repurchased 2,412,900 shares, representing 0.2% for CNY 38 million. With this, the company has completed the repurchase of 2,412,900 shares, representing 0.2% for CNY 38 million under the buyback announced on August 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.06 CNY | +1.01% | +19.49% | -11.64% |
Apr. 25 | Yifan Unit's Allergy Drug Passes China Regulatory Test, Stock Price Jumps | MT |
Apr. 25 | Yifan Pharmaceutical's Unit Gets Nod to Register Nimodipine Injection | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.64% | 2.19B | |
+21.16% | 43.34B | |
+20.44% | 21.96B | |
+11.05% | 14.09B | |
+13.09% | 13.64B | |
+39.57% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- 002019 Stock
- News Yifan Pharmaceutical Co., Ltd.
- Tranche Update on Yifan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 31, 2023.